The scientific training and experience considered appropriate by the sponsor to qualify the Investigators as suitable experts to Investigate the safety of the drug, bearing In mind what is known about the pharmacological action of the drug and the phase... Drug Safety - Page 839by United States. Congress. House. Committee on Government Operations - 1964Full view - About this book
| Administrative law - 1987 - 996 pages
...with the drug under investigation and related drugs for the information of clinical investigators. 8. The scientific training and experience considered...Investigators as suitable experts to Investigate the safety of the drug, bearing In mind what is known about the pharmacological action of the drug and... | |
| Administrative law - 1971 - 676 pages
...drug under Investigation and related drugs for the Information of clinical investigators. ยง 130.3 8. The scientific training and experience considered...Investigators as suitable experts to Investigate the safety of the drug, bearing In mind what Is known about the pharmacological action of the drug and... | |
| Administrative law - 1981 - 1252 pages
...with the drug under investigation and related drugs for the information of clinical investigators. 8. The scientific training and experience considered...investigators as suitable experts to investigate the safety of the drug, bearing in mind what is known about the pharmacological action of the drug and... | |
| United States. Congress. House. Interstate and Foreign Commerce - 1962 - 732 pages
...by prior investigations and experience with the drug for the information of clinical investigators. "8. The scientific training and experience considered appropriate by the sponsor to quality the investigators as suitable experts to investigate the safety of the drug, bearing in mind... | |
| Administrative law - 1969 - 698 pages
...under lnvestigation and related drugs for the lnformation of clinical lnvestigators. 8. The sclentific training and experience considered appropriate by...investigators as suitable experts to investigate the safety of the drug, bearing ln mind what is known about the pharmacological action of the drug and... | |
| |